A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients
A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients
NCT ID: NCT03019250 Phase: NA Status: COMPLETED Enrollment: 200 Completion: 2018-11-07
Conditions
Critical Illness, Infection Complication, Multiple Organ Dysfunction Syndrome
Interventions
Colostrum, Maltodextrin
Summary
Enteral administration of immune-modulating nutrients such as glutamine, omega-3 fatty acids, selenium, and antioxidants has been suggested to reduce infections and improve recovery from critical illness. However, the effects of colostrum on clinical outcomes in critical ill patients has not been investigated. In current trial, intensive care unit patients with enteral feeding will receive either enteral colostrum or maltodextrin as placebo.
Primary Outcome
Occurrence of infection